Indications
Picato is indicated for the cutaneous treatment of non?hyperkeratotic, non?hypertrophic actinic keratosis in adults.
Composition
- Active substance
- Ingenol mebutate
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Picato
- Active substance
- Ingenol mebutate
- ATC code
- D06BX02
- Group
- Dermatologicals
- Therapeutic area
- Keratosis, Actinic
- Marketing authorisation holder
- LEO Laboratories Ltd.
- Status
- Withdrawn
- EU authorisation
- 15 Nov 2012
- EMA product number